BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17389912)

  • 1. Fully differentiated HIV-1 specific CD8+ T effector cells are more frequently detectable in controlled than in progressive HIV-1 infection.
    Addo MM; Draenert R; Rathod A; Verrill CL; Davis BT; Gandhi RT; Robbins GK; Basgoz NO; Stone DR; Cohen DE; Johnston MN; Flynn T; Wurcel AG; Rosenberg ES; Altfeld M; Walker BD
    PLoS One; 2007 Mar; 2(3):e321. PubMed ID: 17389912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV replication leads to skewed maturation of CD8-positive T-cell responses in infected children.
    Montesano C; Anselmi A; Palma P; Bernardi S; Cicconi R; Mattei M; Castelli-Gattinara G; Ciccozzi M; Colizzi V; Amicosante M
    New Microbiol; 2010 Oct; 33(4):303-9. PubMed ID: 21213588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of virus-specific CD8(+) effector T cells in the course of HIV-1 infection: longitudinal analyses in slow and rapid progressors.
    Jansen CA; Piriou E; Bronke C; Vingerhoed J; Kostense S; van Baarle D; Miedema F
    Clin Immunol; 2004 Dec; 113(3):299-309. PubMed ID: 15507395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment.
    Emu B; Sinclair E; Favre D; Moretto WJ; Hsue P; Hoh R; Martin JN; Nixon DF; McCune JM; Deeks SG
    J Virol; 2005 Nov; 79(22):14169-78. PubMed ID: 16254352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequencies of ex vivo-activated human immunodeficiency virus type 1-specific gamma-interferon-producing CD8+ T cells in infected children correlate positively with plasma viral load.
    Buseyne F; Scott-Algara D; Porrot F; Corre B; Bellal N; Burgard M; Rouzioux C; Blanche S; Rivière Y
    J Virol; 2002 Dec; 76(24):12414-22. PubMed ID: 12438567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.
    Hunt PW; Brenchley J; Sinclair E; McCune JM; Roland M; Page-Shafer K; Hsue P; Emu B; Krone M; Lampiris H; Douek D; Martin JN; Deeks SG
    J Infect Dis; 2008 Jan; 197(1):126-33. PubMed ID: 18171295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point.
    Northfield JW; Loo CP; Barbour JD; Spotts G; Hecht FM; Klenerman P; Nixon DF; Michaëlsson J
    J Virol; 2007 Jun; 81(11):5759-65. PubMed ID: 17376902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fully immunocompetent CD8+ T lymphocytes are present in autologous haematopoietic stem cell transplantation recipients despite an ineffectual T-helper response.
    Bandera A; Trabattoni D; Pacei M; Fasano F; Suardi E; Cesari M; Marchetti G; Pogliani EM; Franzetti F; Clerici M; Gori A
    PLoS One; 2008; 3(10):e3616. PubMed ID: 18974880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of changes in antigen level on CD38/PD-1 co-expression on HIV-specific CD8 T cells in chronic, untreated HIV-1 infection.
    Vollbrecht T; Brackmann H; Henrich N; Roeling J; Seybold U; Bogner JR; Goebel FD; Draenert R
    J Med Virol; 2010 Mar; 82(3):358-70. PubMed ID: 20087935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited sequence evolution within persistently targeted CD8 epitopes in chronic human immunodeficiency virus type 1 infection.
    Koibuchi T; Allen TM; Lichterfeld M; Mui SK; O'Sullivan KM; Trocha A; Kalams SA; Johnson RP; Walker BD
    J Virol; 2005 Jul; 79(13):8171-81. PubMed ID: 15956562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 specific CD8+ T cells with an effector phenotype and control of viral replication.
    Hess C; Altfeld M; Thomas SY; Addo MM; Rosenberg ES; Allen TM; Draenert R; Eldrige RL; van Lunzen J; Stellbrink HJ; Walker BD; Luster AD
    Lancet; 2004 Mar; 363(9412):863-6. PubMed ID: 15031033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression to CMV end-organ disease in HIV-1-infected individuals despite abundance of highly differentiated CMV-specific CD8+ T-cells.
    Bronke C; Westerlaken GH; Miedema F; Tesselaar K; van Baarle D
    Immunol Lett; 2005 Mar; 97(2):215-24. PubMed ID: 15752561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between the frequency of HIV-specific CD8+ T cells and the level of CD38+CD8+ T cells in untreated HIV-infected individuals.
    Chun TW; Justement JS; Sanford C; Hallahan CW; Planta MA; Loutfy M; Kottilil S; Moir S; Kovacs C; Fauci AS
    Proc Natl Acad Sci U S A; 2004 Feb; 101(8):2464-9. PubMed ID: 14983032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy.
    Zhang Z; Zhao QX; Fu JL; Yao JX; He Y; Jin L; Wang FS
    Chin Med J (Engl); 2006 Dec; 119(23):1949-57. PubMed ID: 17199938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype.
    Gillespie GM; Pinheiro S; Sayeid-Al-Jamee M; Alabi A; Kaye S; Sabally S; Sarge-Njie R; Njai H; Joof K; Jaye A; Whittle H; Rowland-Jones S; Dorrell L
    Eur J Immunol; 2005 May; 35(5):1445-53. PubMed ID: 15832290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection.
    Allen TM; Yu XG; Kalife ET; Reyor LL; Lichterfeld M; John M; Cheng M; Allgaier RL; Mui S; Frahm N; Alter G; Brown NV; Johnston MN; Rosenberg ES; Mallal SA; Brander C; Walker BD; Altfeld M
    J Virol; 2005 Oct; 79(20):12952-60. PubMed ID: 16188997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superior control of HIV-1 replication by CD8+ T cells targeting conserved epitopes: implications for HIV vaccine design.
    Kunwar P; Hawkins N; Dinges WL; Liu Y; Gabriel EE; Swan DA; Stevens CE; Maenza J; Collier AC; Mullins JI; Hertz T; Yu X; Horton H
    PLoS One; 2013; 8(5):e64405. PubMed ID: 23741326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high viral burden predicts the loss of CD8 T-cell responses specific for subdominant gag epitopes during chronic human immunodeficiency virus infection.
    Geldmacher C; Gray C; Nason M; Currier JR; Haule A; Njovu L; Geis S; Hoffmann O; Maboko L; Meyerhans A; Cox J; Hoelscher M
    J Virol; 2007 Dec; 81(24):13809-15. PubMed ID: 17898052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective IL-2 production by HIV-1-specific CD4 and CD8 T cells in an adolescent/young adult cohort.
    Kapogiannis BG; Henderson SL; Nigam P; Sharma S; Chennareddi L; Herndon JG; Robinson HL; Amara RR
    AIDS Res Hum Retroviruses; 2006 Mar; 22(3):272-82. PubMed ID: 16545014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skewed maturation of memory HIV-specific CD8 T lymphocytes.
    Champagne P; Ogg GS; King AS; Knabenhans C; Ellefsen K; Nobile M; Appay V; Rizzardi GP; Fleury S; Lipp M; Förster R; Rowland-Jones S; Sékaly RP; McMichael AJ; Pantaleo G
    Nature; 2001 Mar; 410(6824):106-11. PubMed ID: 11242051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.